HKD 0.61
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 141.83 Million USD | -7.53% |
2022 | 153.37 Million USD | -41.18% |
2021 | 260.75 Million USD | 110.86% |
2020 | 123.66 Million USD | 11.7% |
2019 | 110.7 Million USD | -84.28% |
2018 | 704.2 Million USD | -30.54% |
2017 | 1.01 Billion USD | 56.51% |
2016 | 647.8 Million USD | 24.97% |
2015 | 518.37 Million USD | -31.61% |
2014 | 758 Million USD | 3.17% |
2013 | 734.69 Million USD | -9.98% |
2012 | 816.17 Million USD | 5.37% |
2011 | 774.57 Million USD | 4.29% |
2010 | 742.72 Million USD | 122.96% |
2009 | 333.12 Million USD | -38.58% |
2008 | 542.35 Million USD | -26.29% |
2007 | 735.76 Million USD | 5.96% |
2006 | 694.36 Million USD | 169.65% |
2005 | 257.51 Million USD | -21.63% |
2004 | 328.6 Million USD | 19.67% |
2003 | 274.59 Million USD | 144.24% |
2002 | 112.43 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 204.9 Million USD | 0.0% |
2023 Q4 | 141.83 Million USD | 0.0% |
2023 FY | 141.83 Million USD | -7.53% |
2023 Q2 | 133.52 Million USD | 0.0% |
2022 Q4 | 153.37 Million USD | 0.0% |
2022 Q2 | 244.98 Million USD | 0.0% |
2022 FY | 153.37 Million USD | -41.18% |
2021 Q2 | 255.66 Million USD | 0.0% |
2021 FY | 260.75 Million USD | 110.86% |
2021 Q4 | 260.75 Million USD | 0.0% |
2020 Q4 | 123.66 Million USD | 0.0% |
2020 FY | 123.66 Million USD | 11.7% |
2020 Q2 | 129.69 Million USD | 0.0% |
2019 Q2 | 840.7 Million USD | 0.0% |
2019 Q4 | 110.7 Million USD | 0.0% |
2019 FY | 110.7 Million USD | -84.28% |
2018 Q2 | 1.14 Billion USD | 0.0% |
2018 Q4 | 704.2 Million USD | 0.0% |
2018 FY | 704.2 Million USD | -30.54% |
2017 Q4 | 1.01 Billion USD | 0.0% |
2017 FY | 1.01 Billion USD | 56.51% |
2017 Q2 | 722.83 Million USD | 0.0% |
2016 Q4 | 647.8 Million USD | 0.0% |
2016 FY | 647.8 Million USD | 24.97% |
2016 Q2 | 637.39 Million USD | 0.0% |
2015 Q2 | 737.73 Million USD | 0.0% |
2015 FY | 518.37 Million USD | -31.61% |
2015 Q4 | 518.37 Million USD | 0.0% |
2014 Q4 | 758 Million USD | 0.0% |
2014 FY | 758 Million USD | 3.17% |
2014 Q2 | 847.69 Million USD | 0.0% |
2013 Q4 | 734.69 Million USD | 0.0% |
2013 Q2 | 801.27 Million USD | 0.0% |
2013 FY | 734.69 Million USD | -9.98% |
2012 Q2 | 980.23 Million USD | 0.0% |
2012 Q4 | 816.17 Million USD | 0.0% |
2012 FY | 816.17 Million USD | 5.37% |
2011 FY | 774.57 Million USD | 4.29% |
2011 Q2 | 1.05 Billion USD | 0.0% |
2011 Q4 | 774.57 Million USD | 0.0% |
2010 Q4 | 742.72 Million USD | 0.0% |
2010 FY | 742.72 Million USD | 122.96% |
2010 Q2 | 720.19 Million USD | 0.0% |
2009 Q4 | 333.12 Million USD | 0.0% |
2009 FY | 333.12 Million USD | -38.58% |
2008 FY | 542.35 Million USD | -26.29% |
2007 FY | 735.76 Million USD | 5.96% |
2006 FY | 694.36 Million USD | 169.65% |
2005 FY | 257.51 Million USD | -21.63% |
2004 FY | 328.6 Million USD | 19.67% |
2003 FY | 274.59 Million USD | 144.24% |
2002 FY | 112.43 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Starlite Holdings Limited | 266.35 Million HKD | 46.751% |
Litu Holdings Limited | 537.22 Million HKD | 73.599% |
Touyun Biotech Group Limited | 586.26 Million HKD | 75.808% |
Champion Alliance International Holdings Limited | 99.22 Million HKD | -42.935% |
Huaxi Holdings Company Limited | 173.29 Million HKD | 18.157% |